chr20-45416226-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015937.6(PIGT):c.70G>A(p.Glu24Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,596,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015937.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGT | NM_015937.6 | c.70G>A | p.Glu24Lys | missense_variant | 1/12 | ENST00000279036.12 | NP_057021.2 | |
LOC107985405 | XR_001754640.2 | n.762C>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGT | ENST00000279036.12 | c.70G>A | p.Glu24Lys | missense_variant | 1/12 | 1 | NM_015937.6 | ENSP00000279036 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000325 AC: 7AN: 215238Hom.: 0 AF XY: 0.0000256 AC XY: 3AN XY: 117012
GnomAD4 exome AF: 0.00000623 AC: 9AN: 1444402Hom.: 0 Cov.: 31 AF XY: 0.00000418 AC XY: 3AN XY: 717148
GnomAD4 genome AF: 0.000105 AC: 16AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74380
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.70G>A (p.E24K) alteration is located in exon 1 (coding exon 1) of the PIGT gene. This alteration results from a G to A substitution at nucleotide position 70, causing the glutamic acid (E) at amino acid position 24 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Multiple congenital anomalies-hypotonia-seizures syndrome 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 16, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 24 of the PIGT protein (p.Glu24Lys). This variant is present in population databases (rs2741582, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PIGT-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PIGT protein function. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at